How should anti-hypertensive medications be adjusted before screening for primary aldosteronism? J Formos Med Assoc. 2024 Mar:123 Suppl 2:S91-S97.doi:10.1016/j.jfma.2023.05.021. Epub 2023 Jun 7. Jin-Ying Lu, Yi-Yao Chang, Ting-Wei Lee, Ming-Hsien Wu, Zheng-Wei Chen, Yen-Ta Huang, Tai-Shuan Lai, Leay Kiaw Er, Yen-Hung Lin, Vin-Cent Wu, Hao-Min Cheng, Hsien-Li Kao, Charles Jia-Yin Hou, Kwan-Dun Wu, Szu-Tah Chen, Feng-Hsuan Liu.
The Risk of Bladder Cancer in Type 2 Diabetes Mellitus with Combination Therapy of SGLT-2 Inhibitors and Pioglitazone. J Pers Med 2021 Aug 24;11(9):828. Yan-Rong Li, Chi-Hung Liu, Wei-Chiao Sun, Pei-Yi Fan, Feng-Hsuan Liu, Tien-Hsing Chen, Victor Chien-Chia Wu, Chihung Lin, Ching-Chung Hsiao.
Endocr Pract 2020 Aug;26(8):818-829. Similar Cardiovascular Outcomes Between Insulin Detemir and Insulin Glargine In Type 2 Diabetic Patients With Extremely Atherosclerotic Cardiovascular Disease Risks Tien-Hsing Chen, Chih-Ching Wang, Chi-Hung Liu, Ching-Chung Hsiao, Szu-Tah Chen, Feng-Hsuan Liu, Ming-Yun Ho, Yan-Rong Li.
The efficacy and safety of concentrated herbal extract granules, YH1, as an add-on medication in poorly controlled type 2 diabetes: A randomized, double-blind, placebo-controlled pilot trial. PLOS ONE 2019, Aug. 15. Yueh-Hsiang Huang, Szu-Tah Chen, Feng-Hsuan Liu, Yi-Hong Wu.
Quality of the multiple-choice questions of the written tests for Endocrinology and Metabolism specialist board exams. Journal of Medical Education 2019;23:125-32. Feng-Hsuan Liu, Deng-Huang Su, Wei-Yih Chiu, Wan-Chen Wu, Hsuan-Ju Huang, Hsin-Yu Su, Fen-Yu Tseng.
Nuclear Medicine Communications 2019;40:568-75. I-131 NP-59 scintigraphy as a useful diagnostic tool for primary aldosteronism at a medical center in North Taiwan: a retrospective study. Ming-Hsien Wu, Feng-Hsuan Liu, Kun-Ju Lin, Szu-Tah Chen.